Novel tricycloundecane derivatives as potential N-methyl-D-aspartate receptor and calcium channel inhibitors for neuroprotection
neuroprotective with fewer side effects and are approved for clinical use. This has led to the development of structurally related polycyclic molecules such as NPG1-01, which exhibit neuroprotective properties…

